TAM
WST icon

Telluride Asset Management’s West Pharmaceutical WST Stock Holding History

Telluride Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5,768
Closed -$254K – 339
2014
Q1 		$254K Buy
+5,768
New +$272K 0.21% 153

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Telluride Asset Management's WST Position: Q2 2014 in Review

Telluride Asset Management sold out of West Pharmaceutical (WST) in Q2 2014, closing a stake of 5,768 shares — an estimated $254K sold.

Telluride Asset Management first reported a position in WST in Q1 2014 and held it in 1 quarter. The position peaked at $254K in Q1 2014. 222 funds tracked by Wall St. Rank hold WST as of Q2 2014.

  • Telluride Asset Management reported no remaining West Pharmaceutical position as of Q2 2014 after selling out during the quarter.
  • Telluride Asset Management sold 5,768 West Pharmaceutical shares in Q2 2014, an estimated $254K.
  • Telluride Asset Management first reported a position in West Pharmaceutical in Q1 2014 and held it in 1 quarter.
  • Telluride Asset Management's West Pharmaceutical position peaked at $254K in Q1 2014.
  • 222 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2014.

Based on Telluride Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.